Full Library
A phase 2 multicenter, prospective, randomized, double-blind study to assess the clinical and antiviral efficacy and safety of nitazoxanide for the treatment of norovirus in hematopoietic stem cell and solid organ transplant recipients
Resource type
Journal Article
Authors/contributors
- Boutin, Catherine-Audrey (Author)
- Callegari, Michelle (Author)
- Florescu, Diana (Author)
- Nguyen, Minh-Hong (Author)
- Kaul, Daniel (Author)
- Avery, Robin (Author)
- Chong, Pearlie (Author)
- Fisher, Cynthia (Author)
- Limaye, Ajit P. (Author)
- Clough, Lisa (Author)
- Pergam, Steven A. (Author)
- Green, Michael (Author)
- Michaels, Marian G. (Author)
- Danziger-Isakov, Lara A. (Author)
- Angarone, Michael (Author)
- Keefer, Laurie (Author)
- Daud, Amna (Author)
- Lorenzo-Redondo, Ramon (Author)
- Tan, Ming (Author)
- Ison, Michael G. (Author)
Title
A phase 2 multicenter, prospective, randomized, double-blind study to assess the clinical and antiviral efficacy and safety of nitazoxanide for the treatment of norovirus in hematopoietic stem cell and solid organ transplant recipients
Publication
American Journal of Transplantation
Publisher
Elsevier
Date
2026-09-01
Volume
26
Issue
9
Pages
2169-2181
Journal Abbr
American Journal of Transplantation
Accessed
9/27/26, 3:41 PM
PMID
42177030
ISSN
1600-6135, 1600-6143
Language
English
Library Catalog
Citation
Boutin, C.-A., Callegari, M., Florescu, D., Nguyen, M.-H., Kaul, D., Avery, R., Chong, P., Fisher, C., Limaye, A. P., Clough, L., Pergam, S. A., Green, M., Michaels, M. G., Danziger-Isakov, L. A., Angarone, M., Keefer, L., Daud, A., Lorenzo-Redondo, R., Tan, M., & Ison, M. G. (2026). A phase 2 multicenter, prospective, randomized, double-blind study to assess the clinical and antiviral efficacy and safety of nitazoxanide for the treatment of norovirus in hematopoietic stem cell and solid organ transplant recipients. American Journal of Transplantation, 26(9), 2169–2181. https://doi.org/10.1016/j.ajt.2026.04.010
Link to this record